Skip to content

WHODAS-II for Patients With Nonspecific Low Back Pain

WHODAS-II for Patients With Nonspecific Low Back Pain

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00479245
Enrollment
200
Registered
2007-05-28
Start date
2007-04-30
Completion date
2011-04-30
Last updated
2011-06-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Low Back Pain

Keywords

nonspecific low back pain, disability, fear avoidance beliefs, quality of life

Brief summary

The main purpose of this study is to determine the measurement characteristics of WHODAS-II (World Health Organization Disability Assessment Schedule), as well as to analyze its correlation with low back pain (Visual Analog Scale, VAS), disability (Spanish version of the Roland Morris Questionnaire, RMQ), fear avoidance beliefs and attitudes (Spanish version of the FAB Questionnaire, FABQ) and quality of life (SF-12). Measurements will be taken at baseline and 6 days later (day 7).

Interventions

To determine the measurement characteristics of WHODAS II (World Health Organization Disability Assessment Schedule)

Sponsors

Kovacs Foundation
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Patients seen for nonspecific low back pain, with or without referred pain * Able to read and write * Have signed the informed consent form

Exclusion criteria

* Central nervous system pathology (with or without treatment) * Diagnosis of rheumatic inflammatory disease or fibromyalgia * Red flags for underlying systemic disease * Criteria for diagnosis of symptomatic herniated disc or symptomatic spinal stenosis

Design outcomes

Primary

MeasureTime frame
Measurement characteristics of WHODAS-IIAt baseline and at 7 days

Secondary

MeasureTime frame
Correlation between WHODAS-II and VAS, RMQ, FABQ and SF-12 in nonspecific low back painAt baseline and at 7 days

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026